Press Release May 14 2026

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.".

View Attachment